2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Systemic Scleroderma: new trials by email Literature Review of Systemic Scleroderma trials Research Report on Systemic Scleroderma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sildenafil Effect on Digital Ulcer Healing in sClerodErma SEDUCE STUDY Sildenafil, placebo - Systemic Scleroderma | Phase 3 | Completed | University Hospital, Lille | 84 | 2010-11-01 | 2026-05-14 |
| Scleroderma Lung Disease Cyclophosphamide, Placebo - Lung Diseases, Pulmonary Fibrosis | Phase 3 | Completed | The University of Texas Health Science Center, Houston | 158 | 1999-08-01 | 2015-03-27 |
Scleroderma, Systemic (2) · Lung Diseases (1) · Pulmonary Fibrosis (1) · Scleroderma, Diffuse (1) · Ulcer (1)
Connective Tissue Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Fibrosis (1) · Lung Diseases, Interstitial (1) · Respiratory Tract Diseases (1)
Cyclophosphamide (1) · Sildenafil Citrate (1)
The University of Texas Health Science Center, Houston (1) · University Hospital, Lille (1)
France (1)
Maureen Mayes (1)
PMID 16790698, PMID 17717203, PMID 17901414, PMID 18641099, PMID 19892673, PMID 21547897, PMID 22156609, PMID 25452309, PMID 25995322, PMID 26704522, PMID 26757749, PMID 28544580, PMID 29099620, PMID 30651141, PMID 41316297
U01HL060839 (1)